Acid-Base and Electrolyte Managements in Chronic Kidney Disease and End-Stage Renal Disease: Case-Based Discussion

被引:6
|
作者
Lin, Jing [2 ]
Cheng, Zhen [3 ]
Ding, Xiaoqiang [2 ]
Qian, Qi [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Med, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA
[2] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai, Peoples R China
[3] Nanjing Univ, Jinling Hosp, Sch Med, Natl Clin Res Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China
关键词
Chronic kidney disease; End-stage renal disease; Metabolic acidosis; Metabolic alkalosis; Hypoxia; Hemodialysis; SERUM BICARBONATE LEVELS; MAINTENANCE HEMODIALYSIS-PATIENTS; DIALYSATE SODIUM CONCENTRATION; METABOLIC-ACIDOSIS; PRACTICE PATTERNS; PATIENTS INCREASES; CARDIAC-ARREST; SUDDEN-DEATH; RISK-FACTORS; MORTALITY;
D O I
10.1159/000485155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acid-base and electrolyte alterations are common in patients with chronic kidney disease (CKD) and end-stage kidney failure (ESRD). The alterations become more complex as CKD advances to ESRD, leading to morbidity and mortality. Three cases are presented illustrating some key prototypic features in CKD and ESRD. Each is accompanied by discussion of pathophysiology, diagnosis, and treatment options. Newer investigational results are integrated into the existing body of knowledge. Although rigorous assessment of various dialysis prescriptions is scanty, in its current state, instituting a well thought-out, multi-pronged management plan to minimize CKD/ESRD and dialysis-related electrolyte and acid-base disruptions is appropriate. There is a pressing need for prospective interventional trials in the future. (c) 2018 S. Karger AG, Basel
引用
收藏
页码:179 / 186
页数:8
相关论文
共 50 条
  • [31] Global case studies for chronic kidney disease/end-stage kidney disease care
    Yang, Chih-Wei
    Harris, David C. H.
    Luyckx, Valerie A.
    Nangaku, Masaomi
    Hou, Fan Fan
    Garcia, Guillermo Garcia
    Abu-Aisha, Hasan
    Niang, Abdou
    Sola, Laura
    Bunnag, Sakarn
    Eiam-Ong, Somchai
    Tungsanga, Kriang
    Richards, Marie
    Richards, Nick
    Goh, Bak Leong
    Dreyer, Gavin
    Evans, Rhys
    Mzingajira, Henry
    Twahir, Ahmed
    McCulloch, Mignon I.
    Ahn, Curie
    Osafo, Charlotte
    Hsu, Hsiang-Hao
    Barnieh, Lianne
    Donner, Jo-Ann
    Tonelli, Marcello
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2020, 10 (01) : E24 - E48
  • [32] Microbial Analysis in Chronic Rhinosinusitis Patients with Chronic Kidney Disease and End-Stage Renal Disease
    Lo, Sheng-Wei
    Ding, Meng-Chang
    Tsai, Yao-Te
    Tsai, Ming-Shao
    Liu, Chia-Yen
    Hsu, Cheng-Ming
    Yang, Yao-Hsu
    Chang, Geng-He
    LARYNGOSCOPE, 2024, 134 (08): : 3499 - 3507
  • [33] End-stage renal disease in sarcoidosis of the kidney
    Tsiouris, N
    Kovacs, B
    Daskal, I
    Brent, LH
    Samuels, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05)
  • [34] Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease
    Mathew, Roy O.
    Bettinger, Jeffrey J.
    Wegrzyn, Erica L.
    Fudin, Jeffrey
    JOURNAL OF PAIN RESEARCH, 2016, 9 : 1191 - 1195
  • [35] Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease
    Mona Khurana
    Douglas M. Silverstein
    Pediatric Nephrology, 2015, 30 : 2073 - 2084
  • [36] Childhood Albuminuria and Chronic Kidney Disease is Associated with Mortality and End-Stage Renal Disease
    Lin, Ching-Yuang
    Huang, Shiuh-Ming
    PEDIATRICS AND NEONATOLOGY, 2016, 57 (04): : 280 - 287
  • [37] Comparison of the Quality of Sleep in Patients With Chronic Kidney Disease and End-Stage Renal Disease
    Mujahid, Mehreen
    Nasir, Kiran
    Qureshi, Ruqaya
    Dhrolia, Murtaza
    Ahmad, Aasim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [38] Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
    O'Seaghdha, Conall M.
    Hwang, Shih-Jen
    Muntner, Paul
    Melamed, Michal L.
    Fox, Caroline S.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) : 2885 - 2890
  • [39] Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review
    Aviral Vij
    Yasmeen Golzar
    Rami Doukky
    Journal of Nuclear Cardiology, 2018, 25 : 137 - 149
  • [40] Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review
    Vij, Aviral
    Golzar, Yasmeen
    Doukky, Rami
    JOURNAL OF NUCLEAR CARDIOLOGY, 2018, 25 (01) : 137 - 149